ANI PHARMACEUTICALS INC (ANIP) Stock Price, Quote, News and Overview
NASDAQ:ANIP - Nasdaq - US00182C1036 - Common Stock - Currency: USD
ANIP Quote, Performance and Key Statistics
68.95
+0.95 (+1.4%)
The current stock price of ANIP is 68.95 USD. In the past month the price increased by 4.5%. In the past year, price increased by 5.49%.
ANIP Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 63.66 | 784.50B | ||
| JNJ | JOHNSON & JOHNSON | 15.7 | 380.15B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 17.17 | 265.94B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.03 | 220.04B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.35 | 210.42B | ||
| MRK | MERCK & CO. INC. | 10.34 | 198.72B | ||
| PFE | PFIZER INC | 7.24 | 127.78B | ||
| SNY | SANOFI-ADR | 11.5 | 126.93B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 43.7 | 101.37B | ||
| GSK | GSK PLC-SPON ADR | 8.38 | 74.22B | ||
| ZTS | ZOETIS INC | 25.34 | 66.90B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 32.62 | 48.25B |
Related stock screener links
About ANIP
Company Profile
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. The company is headquartered in Baudette, Minnesota and currently employs 897 full-time employees. The company went IPO on 2000-05-04. The firm is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel, as well as its generics business with enhanced research and development capabilities. Its three pharmaceutical manufacturing facilities, of which two are located in Baudette, Minnesota, and one is located in East Windsor, New Jersey, are together capable of producing oral solid dose products, as well as semi-solids, liquids and topicals, controlled substances, and potent products. The firm has a commercial portfolio of approximately 118 products with a variety of indications and a robust portfolio of pipeline products.
Company Info
ANI PHARMACEUTICALS INC
210 Main Street West
Baudette MINNESOTA 56623 US
CEO: Nikhil Lalwani
Employees: 642
Company Website: https://www.anipharmaceuticals.com/
Investor Relations: https://investor.anipharmaceuticals.com
Phone: 12186343500
ANI PHARMACEUTICALS INC / ANIP FAQ
What is the stock price of ANI PHARMACEUTICALS INC today?
The current stock price of ANIP is 68.95 USD. The price increased by 1.4% in the last trading session.
What is the ticker symbol for ANI PHARMACEUTICALS INC stock?
The exchange symbol of ANI PHARMACEUTICALS INC is ANIP and it is listed on the Nasdaq exchange.
On which exchange is ANIP stock listed?
ANIP stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ANI PHARMACEUTICALS INC stock?
14 analysts have analysed ANIP and the average price target is 82.62 USD. This implies a price increase of 19.83% is expected in the next year compared to the current price of 68.95. Check the ANI PHARMACEUTICALS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ANI PHARMACEUTICALS INC worth?
ANI PHARMACEUTICALS INC (ANIP) has a market capitalization of 1.49B USD. This makes ANIP a Small Cap stock.
How many employees does ANI PHARMACEUTICALS INC have?
ANI PHARMACEUTICALS INC (ANIP) currently has 642 employees.
What are the support and resistance levels for ANI PHARMACEUTICALS INC (ANIP) stock?
ANI PHARMACEUTICALS INC (ANIP) has a support level at 65.61 and a resistance level at 69.21. Check the full technical report for a detailed analysis of ANIP support and resistance levels.
Is ANI PHARMACEUTICALS INC (ANIP) expected to grow?
The Revenue of ANI PHARMACEUTICALS INC (ANIP) is expected to grow by 28.29% in the next year. Check the estimates tab for more information on the ANIP EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ANI PHARMACEUTICALS INC (ANIP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ANIP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ANIP, evaluating the profitability, health, valuation and growth aspects
- ANI PHARMACEUTICALS INC (ANIP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ANI PHARMACEUTICALS INC (ANIP) Sales and EPS estimates to see what analysts future expectations are.
- ANI PHARMACEUTICALS INC (ANIP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ANI PHARMACEUTICALS INC (ANIP) Insider and Institutional Ownership to learn about the owners and their transactions.
- ANI PHARMACEUTICALS INC (ANIP) Stock Chart to make your own analysis
- ANI PHARMACEUTICALS INC (ANIP) Latest news and press-releases to stay up to date.
Does ANI PHARMACEUTICALS INC (ANIP) stock pay dividends?
ANIP does not pay a dividend.
When does ANI PHARMACEUTICALS INC (ANIP) report earnings?
ANI PHARMACEUTICALS INC (ANIP) will report earnings on 2025-05-09, before the market open.
What is the Price/Earnings (PE) ratio of ANI PHARMACEUTICALS INC (ANIP)?
The PE ratio for ANI PHARMACEUTICALS INC (ANIP) is 13.26. This is based on the reported non-GAAP earnings per share of 5.2 and the current share price of 68.95 USD. Check the full fundamental report for a full analysis of the valuation metrics for ANIP.
What is the Short Interest ratio of ANI PHARMACEUTICALS INC (ANIP) stock?
The outstanding short interest for ANI PHARMACEUTICALS INC (ANIP) is 14.5% of its float. Check the ownership tab for more information on the ANIP short interest.
ANIP Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to ANIP. When comparing the yearly performance of all stocks, ANIP is one of the better performing stocks in the market, outperforming 87.96% of all stocks.
ANIP Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ANIP. ANIP has only an average score on both its financial health and profitability.
ANIP Financial Highlights
Over the last trailing twelve months ANIP reported a non-GAAP Earnings per Share(EPS) of 5.2. The EPS increased by 10.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.3% | ||
| ROE | -0.9% | ||
| Debt/Equity | 1.43 |
ANIP Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to ANIP. The Buy consensus is the average rating of analysts ratings from 14 analysts.
For the next year, analysts expect an EPS growth of 23.99% and a revenue growth 28.29% for ANIP